SCHEMBL20182174

SCHEMBL20182174

Cc1cn(Cc2cnn(-c3ccccc3F)c2)c2ncnc(Cl)c12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 1/20 0.40
DRD4 P21917 1/20 0.40
DRD3 P35462 1/20 0.40
KMT2A Q03164 3/20 0.40
MEN1 O00255 2/20 0.40
NR2F2 P24468 1/20 0.40
KDM4E B2RXH2 3/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
CFTR P13569 3/20 0.37
DYRK1B Q9Y463 3/20 0.37
P2RX7 Q99572 2/20 0.36
KCNH2 Q12809 1/20 0.35
SCN5A Q14524 1/20 0.35
SCN9A Q15858 1/20 0.35
GRM4 Q14833 1/20 0.35
HPGD P15428 3/20 0.34
LMNA P02545 2/20 0.34
TSHR P16473 2/20 0.34
HTT P42858 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20162937 0.87 DRD2 (0.40) DRD2DRD4DRD3KMT2AMEN1
SCHEMBL30037541 0.87 DRD2 (0.40) DRD2DRD4DRD3KMT2AMEN1
SCHEMBL20182201 0.81 NOTUM (0.48) CFTRKCNH2GRIN2B
SCHEMBL20168137 0.81 FGFR1 (0.46) DRD2DRD4DRD3KMT2AMEN1
SCHEMBL20181874 0.77 CFTR (0.41) KMT2AMEN1NR2F2CFTRDYRK1B
SCHEMBL20162696 0.77 CFTR (0.44) DRD2DRD4DRD3KMT2AMEN1
SCHEMBL20162900 0.76 SRC (0.47) CFTR
SCHEMBL20162862 0.73 RET (0.47) DRD2DRD4DRD3KMT2AMEN1
SCHEMBL20181869 0.73 MEN1 (0.36) KMT2AMEN1NR2F2KCNH2SCN5A
SCHEMBL30538103 0.71 CFTR (0.55) DRD2DRD4DRD3CFTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018094137-A1 PYRROLOPYRIMIDINES AS CFTR POTENTIATORS CYSTIC FIBROSIS FOUNDATION THERAPEUTICS INC. (US) 2018-05-24 WO disclosed